参 考 文 献
[1]蒋学风,罗新.生物膜与阴道炎症[J]. 现代妇产科进展,2011,20(2):146–148.
[2] Patterson JL, Stull－Lane A, Girerd PH, et al.Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosis-associated anaerobes[J].Microbiology,2010,156(2):392-399.
[3] Srinivasan S, Fredricks DN. The human vaginal bacterial biota and bacterial vaginosis[J].Interdisciplinary Perspectives on Infectious Diseases,2008,2008:750479.
[4] Gelber SE, Aguilar JL, Lewis KL,et al.Functional and phylogenetic characterization of vaginolysin, the human-specific cytolysin from Gardnerellavaginal is[J].Journal of Bacteriology,2008,190(11):3896–3903.
[5] Cauci S, Culhane JF, Di Santolo,et al.Among pregnant women with bacterial vaginosis, the hydrolytic enzymes sialidase and prolidase are positively associated with interleukin-1beta[J]. American Journal of Obstetrics & Gynecology ,2008,198（1）：132.e1-e7.
[6] Harwich MD Jr, Alves JM, Buck GA,et al. Drawing the line between commensal and pathogenic Gardnerella vaginalis through genome analysis and virulence studies[J]. BMC Genomics,2010,11(11):375.
[7] Santiago GL, Deschaght P, El Aila N,et al. Gardnerella vaginalis comprises three distinct genotypes of which only two produce sialidase[J]. American Journal of Obstetrics & Gynecology, 2011,204(5): 450.e1-e7.
[8] 李桂军,姚莉,张红霞 ,等. 阴道加德纳菌、Uu、Mh、CT在BV感染进程及诊断价值[J]. 中国卫生检验杂志, 2009,19(9):2105-2107.
[9] Swidsinski A, Mendling W, Loening-Baucke V, et al. Adherent biofilms in bacterial vaginosis[J]. Gynecol Obstet Invest, 2005,106(5 Pt 1):1013–1023.
[10] Swidsinski A, Doerffel Y, Loening-Baucke V, et al. Gardnerella biofilm involves females and males and is transmitted sexually[J]. Gynecol Obstet Invest, 2010,70(4):256-263.
[11] 肖永红 王进 朱燕 高磊,等.Mohnarin 2008年度报告：淋病奈瑟菌、阴道加德纳菌、气单胞菌与副溶血弧菌耐药性分析[J]. 中国抗生素杂志,2010,35(7):S5-S8.,
[12]Swidsinski A, Mendling W, Loening-Baucke V,et al.An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole[J]. American Journal of Obstetrics & Gynecology, 2008, 198(1): 97.e1-e6.
[13]Swidsinski A, Dörffel Y, Loening-Baucke V, et al. Response of Gardnerella vaginalis biofilm to 5 days of moxifloxacin treatment[J]. FEMS Immunology & Medical Microbiology, 2011,61(1):41-46.
[14] Patterson JL, Girerd PH, Karjane NW, et al.Effect of biofilm phenotype on resistance of Gardnerella vaginalis to hydrogen peroxide and lactic acid[J].American Journal of Obstetrics & Gynecology, 2007,197(2):170.e1-e7.
[15] Saunders S, Bocking A, Challis J,et al. Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms[J]. Colloids Surf B Biointerfaces,2007 ,55(2):138-142.
[16] Anukam K, Osazuwa E, Ahonkhai I,et al.Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial[J]. Microbes and Infection, 2006,8(6):1450-1454.
[17]Larsson PG , Brandsborg E , Forsum U ,et al. Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses[J]. BMC Infectious Diseases, 2011,19(11):223.
[18] Senok AC , Verstraelen H , Temmerman M ,et al. Probiotics for the treatment of bacterial vaginosis[J]. Cochrane Database of Systematic Reviews, 2009, 7(4): CD006289
[19]Shirtliff ME, Peters BM, Jabra-Rizk MA. Cross-kingdom interactions: Candida albicans and bacteria[J]. FEMS Microbiology Letters, 2009 ,299(1):1-8 .
[20]Morales DK, Hogan DA.Candida albicans interactions with bacteria in the context of human health and disease[J]. PLoS Pathogens, 2010,6(4):e1000886.
